Gut Microbiota and Diabetes
10.4093/jkd.2024.25.3.117
- Author:
Young Sang LYU
1
;
Jin Hwa KIM
;
Sang Yong KIM
Author Information
1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Chosun University Hospital, Chosun University School of Medicine, Gwangju, Korea
- Publication Type:Opinion
- From:Journal of Korean Diabetes
2024;25(3):117-123
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Type 2 diabetes is rapidly increasing worldwide and is closely linked to factors such as obesity, genetic predispositions, and lifestyle choices. Recent studies emphasize the significant role of gut microbiota in the development and progression of diabetes and other related metabolic diseases. It is also known that the effects and side effects of antidiabetic drugs can be influenced by gut microbiota. Recently, various therapeutic strategies have aimed at modulating gut microbiota for health improvement. Key approaches include the use of probiotics to enhance the balance of beneficial bacteria and prebiotics, which are dietary fibers that promote the growth of these beneficial bacteria. Additionally, the potential of fecal microbiota transplantation in restoring a balanced microbiota composition in individuals with metabolic diseases are explored. This review highlights the promising potential of these interventions in the prevention and management of type 2 diabetes, suggesting that gut microbiota could be a novel and effective approach in diabetes treatment and control.
